Chemoinformaics analysis of 2-Isopropyl-1,4-hexadiene
| Molecular Weight | 124.227 | nRot | 3 |
| Heavy Atom Molecular Weight | 108.099 | nRig | 13 |
| Exact Molecular Weight | 124.125 | nRing | 0 |
| Solubility: LogS | -5.104 | nHRing | 0 |
| Solubility: LogP | 4.337 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 25.6987 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.664 |
| Synth | 5.331 |
| Natural Product Likeliness | 3.032 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.012 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -4.694 |
| MDCK | 0.0000169 |
| BBB | 0.757 |
| PPB | 0.927299 |
| VDSS | 1.062 |
| FU | 0.146116 |
| CYP1A2-inh | 0.057 |
| CYP1A2-sub | 0.576 |
| CYP2c19-inh | 0.136 |
| CYP2c19-sub | 0.926 |
| CYP2c9-inh | 0.218 |
| CYP2c9-sub | 0.866 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.871 |
| CYP3a4-inh | 0.1 |
| CYP3a4-sub | 0.181 |
| CL | 12.655 |
| T12 | 0.063 |
| hERG | 0.012 |
| Ames | 0.016 |
| ROA | 0.097 |
| SkinSen | 0.417 |
| Carcinogencity | 0.024 |
| EI | 0.462 |
| Respiratory | 0.945 |
| NR-Aromatase | 0.286 |
| Antiviral | No |
| Prediction | 0.954747 |